hotspot -WSS

hotspot

author：focus 2025-09-27 09:55:11 - browse：98891

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Chemotherapy drug shortage eases slightly but still widespread

focus

WSS

FDA approves Moderna’s RSV vaccine, its second licensed product

Senate panel eyes new effort on drug shortages

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Chemotherapy drug shortage eases slightly but still widespread

The most pressing bird flu mysteries scientists want answered

hotspot

hotspot

knowledge

Apple is now the first public company to be valued at $3 trillion

An outdated Medicare rule harms dementia patients with anxiety

Drug repurposing or repositioning? The language matters

Eli Lilly’s Zepbound improved liver scarring in mid

ChatGPT in medicine: STAT answers readers' burning questions

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Tori Bowie and the unacceptable rates of Black maternal death

'Little Tech' descents on D.C., wanting a say in how AI is regulated

DIEP, the 'gold standard' of breast reconstruction, is under threat

Phenylephrine and the overlooked value of the placebo effect

focus

A virus, fished out of a lake, may have saved a man’s life

Senators tussle over abortion against the backdrop of a presidential campaign

FDA approves Moderna’s RSV vaccine, its second licensed product

Physician executives need more than on

AI can decode, harness the power of the humane immune system

For pregnant people, addiction treatment shouldn't mean a call to child protective services

focus

knowledge

leisure time

Wikipedia